Grant: Training Grant

Progress in biomedical research is driving an unprecedented pace of discovery in the understanding of the molecular mechanisms of disease. However, despite this progress, there is an enormous gap between the discovery of tools that improve our knowledge of disease processes and the numbers of new therapies "translated" to the bedside. This proposal for a Drug Development Training Program (DDTP) is based on the premise that introducing students to strategies designed to develop candidate molecules into useful drugs will accelerate translation and lead to a greater impact of basic research on disease management. This program brings together strong basic science and clinical research at McGill University and the McGill University Health Centre (MUHC) together with local Biopharmaceutical Industry partners to expose students to the process, successes and failures of state-of-the-art drug development efforts. It is our goal that DDTP will train the academic and industry leaders who will develop the next generation of therapies to benefit all Canadians.